-640x358.jpg&w=3840&q=75)
Cryptocurrency
Strategy tops 700K Bitcoin with $2.1B purchase
Michael Saylor’s Strategy has crossed 700,000 bitcoin holdings following a $2.1bn acquisition.
Isaac Francis
Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Articles by Isaac Francis
Cryptocurrency
USDT demand falls in Venezuela as market expectations shift
USDT prices in Venezuela have fallen sharply as dollar demand eases amid shifting economic expectations.
-640x358.jpg&w=3840&q=75)
Harari warns AI could overtake law religion and finance
Yuval Noah Harari says AI may soon challenge human control over law religion and finance if left unchecked.
Massachusetts judge blocks Kalshi sports betting access
A Massachusetts court has blocked Kalshi from offering sports betting to residents amid legal action by the state.
KYC seen as key to curbing insider trading on prediction markets
Messari warns that without KYC checks, insider trading on prediction markets is extremely difficult to prevent.
Mining
Metallium raises $75M in US-led capital boost
Metallium (ASX:MTM) has completed a $75 million strategic capital raising, led by US-based institutional investors.
Mining
EcoGraf reports high-grade gold hits at Hazina prospect
EcoGraf (ASX:EGR) has announced results from its first exploration campaign at the Hazina prospect, part of its Southern Frontier Gold Project in Tanzania.
Mining
New Murchison Gold reports strong first quarter at Crown Prince Mine
New Murchison Gold (ASX: NMG) has reported robust production results from its Crown Prince Gold Mine, completing its first full quarter of operations.
-640x359.jpg&w=3840&q=75)
Health
Anteris Technologies announces $200M public offering
Anteris Technologies Global (ASX:AVR) announced plans for a proposed US$200 million underwritten public offering of common stock.
Health
Viatris launches first-in-class heart failure drug Inpefa in UAE
Viatris (NASDAQ:VTRS) has officially commenced the global expansion of its cardiovascular portfolio with the launch of Inpefa (sotagliflozin) in the United Arab Emirates, marking the first commercial availability of the therapy outside the United States.